Holen Sie sich die Stockscreener-App
136.01
0.37%
0.50
Handel nachbörslich:
136.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$135.51
Offen:
$135.17
24-Stunden-Volumen:
3.13M
Relative Volume:
1.42
Marktkapitalisierung:
$38.41B
Einnahmen:
$7.23B
Nettoeinkommen (Verlust:
$1.41B
KGV:
27.32
EPS:
4.979
Netto-Cashflow:
$1.09B
1W Leistung:
+7.04%
1M Leistung:
+18.19%
6M Leistung:
-1.72%
1J Leistung:
+13.89%
1-Tages-Spanne:
$134.98
$137.50
1-Wochen-Bereich:
$125.57
$138.62
52-Wochen-Spanne:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Price to earnings forward of Agilent Technologies, Inc. – NYSE:A - TradingView
Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Why Is Agilent (A) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? - Kalkine Media
Agilent finalizes Biocare Medical takeover - MedTech Dive
Agilent 8890 GC System from Agilent Technologies Inc.flexible chromatograph for demanding labs - Ad-hoc-news.de
Bernstein SocGen resumes Agilent stock coverage with outperform rating - Investing.com
Agilent (A) Receives Outperform Rating with $155 Price Target - GuruFocus
Bernstein SocGen resumes Agilent stock coverage with outperform rating By Investing.com - Investing.com Canada
Agilent Technologies, Inc. (NYSE:A) Passed Our Checks, And It's About To Pay A US$0.255 Dividend - simplywall.st
Agilent Technologies completes Biocare deal, shares react to healthcare expansion - Ad-hoc-news.de
Agilent Technologies Closes $600 Million 4.900% Senior Notes Due 2032 Offering and Registration Rights Agreement - Minichart
The 6495D Triple Quadrupole LC/MS from Agilent Technologies Inc.ultra-low detection limits for de - Ad-hoc-news.de
Agilent Technologies, Inc. Actuals & Estimates (BIVA:A) - TradingView
Agilent Technologies (A) Announces $600 Million Senior Notes Off - GuruFocus
Agilent (A) Stock Trades Up, Here Is Why - Yahoo Finance
Agilent Technologies, Inc. Actuals & Estimates (EUROTLX:4A) - TradingView
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Sells $600 Million of 4.900% Senior Notes Due 2032 in Private Offering - TradingView
Agilent (NYSE: A) issues $600M 4.900% senior notes maturing in 2032 - Stock Titan
Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 - marketscreener.com
Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. - marketscreener.com
Agilent Technologies earnings outlook steady, shares tracked on NYSE - Ad-hoc-news.de
Agilent completes acquisition of Biocare Medical - Investing.com UK
Agilent completes $950 million Biocare acquisition - grafa.com
Agilent Completes Acquisition of Biocare Medical - Contract Pharma
Agilent Technologies lifts guidance, shares extend recent NYSE gains - Ad-hoc-news.de
Agilent (A) Finalizes Acquisition of Biocare Medical - GuruFocus
Agilent Completes Biocare Medical Acquisition to Expand Pathology Diagnostics Portfolio - citybiz
Agilent: Acquisition Expected to Be Accretive to Top-Line Growth Rate, Margin Profile and Non-Instrument Rev Mix in the First Yr >A - Moomoo
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler - Insider Monkey
Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group - marketscreener.com
Agilent completes acquisition of Biocare Medical By Investing.com - Investing.com Canada
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies - The Manila Times
A6433334 Bond Price and Chart — FINRA:A6433334 - TradingView
A Look at Agilent Technologies Inc (A) After 3.9% Gain -- GF Val - GuruFocus
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Is the options market predicting a spike in Agilent Technologies stock? - MSN
Agilent Technologies lifts full-year guidance, shares react to Ignite strategy - Ad-hoc-news.de
How Agilent’s Upgraded Outlook and Cancer Diagnostics Push Could Impact Agilent Technologies (A) Investors - Sahm
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Form 8K Agilent Technologies For: 23 June By Investing.com - Investing.com Nigeria
Form 6K Agilent Technologies For: 23 June By Investing.com - Investing.com Canada
Barclays Adjusts Price Target on Agilent Technologies to $150 From $145, Maintains Overweight Rating - Moomoo
Agilent Technologies options draw attention, analysts keep a cautious stance on the shares - AD HOC NEWS
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
The InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.mid-range HPLC workhorse - AD HOC NEWS
Is the Options Market Predicting a Spike in Agilent Technologies Stock? - Yahoo Finance
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):